Predictions
PDS Biotechnology Corp.
Start price
Target price
Perf. (%)
€6.75
14.11.22
14.11.22
€10.00
14.11.23
14.11.23
31.66%
17.11.22
17.11.22
Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€4.80
14.11.22
14.11.22
-
14.11.23
14.11.23
-13.88%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
MacroGenics Inc.
Start price
Target price
Perf. (%)
€7.15
13.11.22
13.11.22
-
13.11.23
13.11.23
-20.98%
26.11.22
26.11.22
Could be worthwhile Investment >10% per year
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€29.85
13.11.22
13.11.22
-
13.12.22
13.12.22
1.61%
14.12.22
14.12.22
Known brand
Could be worthwhile Investment >10% per year
Mediclin AG
Start price
Target price
Perf. (%)
€3.32
13.11.22
13.11.22
€3.00
13.11.23
13.11.23
-0.60%
26.11.22
26.11.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Crossject S.A.
Start price
Target price
Perf. (%)
€4.04
12.11.22
12.11.22
€4.50
12.11.23
12.11.23
5.82%
13.11.23
13.11.23
Could be worthwhile Investment >10% per year
Oncopeptides AB
Start price
Target price
Perf. (%)
€1.96
12.11.22
12.11.22
€0.000
12.11.23
12.11.23
-17.89%
26.11.22
26.11.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
AstraZeneca plc
Start price
Target price
Perf. (%)
€124.30
11.11.22
11.11.22
€165.00
08.09.26
08.09.26
18.46%
10:27
10:27
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
Acelrx Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.91
08.11.22
08.11.22
€4.20
08.11.23
08.11.23
23.85%
16.11.22
16.11.22
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€100.60
08.11.22
08.11.22
€150.00
31.01.25
31.01.25
5.77%
05.05.23
05.05.23
Could be worthwhile Investment >10% per year
Syneos Health, Inc.
Start price
Target price
Perf. (%)
€26.12
04.11.22
04.11.22
-
04.11.23
04.11.23
23.91%
10.11.22
10.11.22
Risky Investment
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€38.20
04.11.22
04.11.22
€32.00
31.12.24
31.12.24
6.81%
21.12.22
21.12.22
Could be very worthwhile Investment >20% year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€370.05
04.11.22
04.11.22
€610.00
04.11.23
04.11.23
44.17%
05.11.23
05.11.23
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.62
03.11.22
03.11.22
-
03.11.23
03.11.23
13.26%
10.11.22
10.11.22
Could be very worthwhile Investment >20% year
Koninklijke Philips Electronics
Start price
Target price
Perf. (%)
€13.13
02.11.22
02.11.22
-
02.11.23
02.11.23
-7.19%
03.11.22
03.11.22
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€758.30
01.11.22
01.11.22
€900.00
01.11.23
01.11.23
-9.34%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€42.60
01.11.22
01.11.22
€55.00
31.12.24
31.12.24
-10.33%
04.11.22
04.11.22
Could be very worthwhile Investment >20% year
Sanofi S.A.
Start price
Target price
Perf. (%)
€88.01
01.11.22
01.11.22
€100.00
31.12.24
31.12.24
13.11%
05.05.23
05.05.23
Could be worthwhile Investment >10% per year
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.47
31.10.22
31.10.22
€18.00
31.12.24
31.12.24
19.77%
31.10.22
31.10.22
Could be very worthwhile Investment >20% year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€362.80
29.10.22
29.10.22
€400.00
29.10.23
29.10.23
6.95%
05.05.23
05.05.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€2.68
29.10.22
29.10.22
-
29.10.23
29.10.23
40.63%
30.10.23
30.10.23
Could be worthwhile Investment >10% per year